Early bone marrow metastasis detection: The additional value of FDG-PET/CT vs. CT imaging

Biomedicine and Pharmacotherapy

Volumn 66, Issue 6, 2012, Pages 448-453

  Evangelista, Laura ^a   Panunzio, Annalori ^b   Polverosi, Roberta ^c   Ferretti, Alice ^d   Chondrogiannis, Sotirios ^d   Pomerri, Fabio ^a,b   Rubello, Domenico ^d   Muzzio, Pier Carlo ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Hospital of San Donà di Piave   (Italy)

^d SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Bone marrow; CT scan; FDG PET CT; Lymphoma; Metastasis; Solid cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; BONE METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CLAVICLE; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMERUS; ILEUM; ILIAC CREST; IMAGE ANALYSIS; LIVER METASTASIS; LUNG CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PRIORITY JOURNAL; RIB; SACRUM; SPINE; STERNUM;

AGED; BIOPSY; BONE MARROW NEOPLASMS; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; ITALY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866157205     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2012.06.004     Document Type: Article

References (19)

1. Schaefer N.G., Strobel K., Taverna C., Hany T.F. Bone involvement in patients with lymphoma: the role of FDG-PET/CT. Eur J Nucl Med Mol Imaging 2007, 34:60-67.
2. Ribrag V., Vanel D., Lebolleux S., Lumbroso J., Couanet D., Bonniaud G., et al. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy. Eur J Radiol 2008, 66:325-331.
3. Cheng G., Chen W., Chamroonrat W., Torigian D.A., Zhwang H., Alavi A. Biopsy versus FDG-PET/CT in initial evaluation of bone marrow involvement in pediatric lymphoma patients. Eur J Nucl Med Mol Imaging 2011, 38:1469-1476.
4. Wang J., Weiss L.M., Chang K.L., et al. Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer 2002, 94:1522-1531.
5. Kotzerke J., Guhlmann A., Moog F., Frickhofen N., Reske S.N. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 1999, 26:31-38.
6. Foo S.S., Mitchell P.L., Berlangieri S.U., Smith C.L., Scott A.M. Positron emission tomography scanning in the assesment of patient with lymphoma. Intern Med J 2004, 34:388-397.
7. Schmidt G.P., Schomberg S.O., Reiser M.F., Baur-Melnyk A. Whole body MR imaging of bone marrow. Eur J of Radiol 2005, 55:33-40.
8. Ben-Haim S., Israel O. Breast cancer: role of SPECT and PET in imaging bone metastases. Seminar Nucl Med 2009, 39:408-415.
9. Evangelista L., Baretta Z., Vinante L., Cervino A.R., Gregianin M., Ghiotto C., et al. Tumor markers and FDG-PET/CT for prediction of disease relapse in patients with breast cancer. Eur J Nucl Med Mol Imaging 2010, 38:293-301.
10. Bredella M.A., Steinbach L., Caputo G., Segall G., Hawkins R. Value of FDG-PET in the assessment of patient with multiple myeloma. Am J Radiol 2005, 184:1199-1204.
11. Muslimani A.A., Farag H.L., Francis S., Spiro T.P., Chaudhry A.A., Chan V.C., et al. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non Hodgkin lymphoma. Am J Clin Oncol 2008, 31:409-412.
12. Pelosi E., Penna D., Deandreis D., Chiappella A., Skanjeti A., Vitolo U., et al. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non Hodgkin's lymphoma and its impact on clinical management. Q J Nucl Med Mol Imaging 2008, 52:9-16.
13. Chiang S.B., Rebenstock A., Guan L., Alavi A., Zhuang H. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG-uptake on FDG-PET imaging. Clin Nucl Med 2003, 28:674-676.
14. Cook G.J.R., Wagner E.A., Fogelman I. Pitfalls and artifacts in 18 FDG-PET and PET/TC oncologic imaging. Semin Nucl Med 2004, 34:122-133.
15. Murata Y., Kubota K., Yukihiro M., Ito K., Watanabe H., Shibuya H. Correlations between 18FDG-uptake by bone marrow and haematological parameters: measurements by PET/CT. Nucl Med Biol 2006, 33:999-1004.
16. Baur A., Stabler A., Bartl R., Lamerz R., Scheidler J., Reiser M. MRI gadolinium enhancement of bone marrow: age related changes in normals and in diffuse neoplastic infiltration. Skeletal Radiol 1997, 26:414-418.
17. Tamburrini O., Cova M.A., Console D., Martingano P. The evolving role of MRI in oncohaematological disorders. Radiol Med 2007, 112:703-721.
18. Iizuka-Mikami M., Nagai K., Yoshida K., et al. Detection of bone marrow and extramedullary involvement in patients with non Hodgkin's lymphoma by whole-body MRI: comparison with bone and 67 Ga scintigraphies. Eur Radiol 2004, 14:74-81.
19. Kazama H.T., Swanston N, Podoloff D.A., Macapinlac H.A. Effect of colony-stimulating factor and conventional-or high-dose chemotherapy on FDG-uptake in bone marrow. Eur J Nucl Med Mol Imaging 2005, 32:1406-1411.